CAMPINA INKS JOINT VENTURE PACT WITH FONTERRA TO STRENGTHEN EXCIPIENTS BUSINESS

DMV International, the pharmaceutical arm of Campina, a Netherlands-based dairy major and the business unit, Lactose New Zealand, a wholly owned subsidiary of Fonterra has teamed-up for excipients manufacture and research. The 50:50 joint venture company known as 'DMV-Fonterra-Excipients GmbH & Co.KG' is expected to play a major role in excipients. Going by the market demand for excipients, the new company is expected to generate a turnover of approx. € 75 million and employ 100-110 people.

Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=34269§ionid=)